The global cellulite treatment market was valued at $2,140.0 million in 2021, and is projected to reach $5,729.06 million by 2031, registering a CAGR of 10.3% from 2022 to 2031.
Cellulite is the herniation of subcutaneous fat within fibrous connective tissue that manifests as skin dimpling and nodularity, often on the pelvic region (specifically the buttocks), lower limbs, and abdomen. The condition is most prevalent in women.
The increase in obesity rate owing to fast food consumption and sedentary lifestyle drive the growth of the market. Weight gain and high obesity are responsible for the development of cellulites. In addition, the increase in the number of cosmetic procedures and the rise in a number of cosmetic clinics contribute toward the growth of the market. For instance, according to International Society of Aesthetic Plastic Surgery (ISAPS) survey, in 2020 about 10,129,528 cosmetic surgical procedures are carried worldwide. The rise in demand for attractive physical appearance in men and women owing to social media influence and celebrities who are popular among the young generation, motivate them to look aesthetically appealing, which provides ample opportunities for market growth. The cellulite treatment, reduces the fat depositions especially from around the thighs and buttocks which further enhances the appearance.
The increase in demand for minimally invasive cosmetic procedures, rise in popularity of cosmetic procedures and genetical factors predominantly in women contribute toward the market growth. Increase in awareness about advanced non-invasive cellulite treatment, and surge in number of cosmetology surgeons are expected to drive the market growth in the coming years.
Moreover, the increase in R&D activities for development of advanced cellulite treatment, product approvals and novel product launch in the market by key players boost the market growth. For instance, in July 2020, Endo International plc, a highly-focused specialty branded and generics pharmaceutical company, has received U. S. Food and Drug Administration (FDA) approval for its, Qwo (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. However, the high cost of advanced cellulite treatment and underdeveloped health care infrastructure in developing countries may hinder the growth of the market.
The cellulite treatment market is segmented on the basis of procedure type, cellulite type, end user and region. By procedure type, the market is divided into non-invasive, minimal invasive and topical. By cellulite type, the market is classified into soft cellulite, hard cellulite, and edematous cellulite. The soft cellulite segment is further divided into male and female. The hard cellulite segment is further bifurcated into male and female. By end user, the market is categorized into hospitals, clinics & beauty centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include ABBVIE, Bausch Health Companies Inc, Candela Syneron, Cynosure, Galderma SA, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma and Teoxane Laboratories.
Cellulite is the herniation of subcutaneous fat within fibrous connective tissue that manifests as skin dimpling and nodularity, often on the pelvic region (specifically the buttocks), lower limbs, and abdomen. The condition is most prevalent in women.
The increase in obesity rate owing to fast food consumption and sedentary lifestyle drive the growth of the market. Weight gain and high obesity are responsible for the development of cellulites. In addition, the increase in the number of cosmetic procedures and the rise in a number of cosmetic clinics contribute toward the growth of the market. For instance, according to International Society of Aesthetic Plastic Surgery (ISAPS) survey, in 2020 about 10,129,528 cosmetic surgical procedures are carried worldwide. The rise in demand for attractive physical appearance in men and women owing to social media influence and celebrities who are popular among the young generation, motivate them to look aesthetically appealing, which provides ample opportunities for market growth. The cellulite treatment, reduces the fat depositions especially from around the thighs and buttocks which further enhances the appearance.
The increase in demand for minimally invasive cosmetic procedures, rise in popularity of cosmetic procedures and genetical factors predominantly in women contribute toward the market growth. Increase in awareness about advanced non-invasive cellulite treatment, and surge in number of cosmetology surgeons are expected to drive the market growth in the coming years.
Moreover, the increase in R&D activities for development of advanced cellulite treatment, product approvals and novel product launch in the market by key players boost the market growth. For instance, in July 2020, Endo International plc, a highly-focused specialty branded and generics pharmaceutical company, has received U. S. Food and Drug Administration (FDA) approval for its, Qwo (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. However, the high cost of advanced cellulite treatment and underdeveloped health care infrastructure in developing countries may hinder the growth of the market.
The cellulite treatment market is segmented on the basis of procedure type, cellulite type, end user and region. By procedure type, the market is divided into non-invasive, minimal invasive and topical. By cellulite type, the market is classified into soft cellulite, hard cellulite, and edematous cellulite. The soft cellulite segment is further divided into male and female. The hard cellulite segment is further bifurcated into male and female. By end user, the market is categorized into hospitals, clinics & beauty centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include ABBVIE, Bausch Health Companies Inc, Candela Syneron, Cynosure, Galderma SA, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma and Teoxane Laboratories.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cellulite treatment market analysis from 2021 to 2031 to identify the prevailing cellulite treatment market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cellulite treatment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cellulite treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Procedure Type
- Non-invasive
- Minimally Invasive
- Topical
By Cellulite Type
- Soft Cellulite
- Gender
- Male
- Female
- Hard Cellulite
- Gender
- Male
- Female
- Edematous
By End User
- Hospitals
- Clinics and Beauty Centers
- Others
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- Abbvie Inc
- Candela Syneron
- Cynosure Technologies
- Merz Pharma GmbH & Co. KGaA
- Bausch Health Companies Inc.
- Hologic Inc
- Zimmer Aesthetics
- Galderma SA
- Sinclair Pharmaceuticals Limited
- Endo International plc
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Non-invasive
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Minimally Invasive
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Topical
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Soft Cellulite
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Soft Cellulite Cellulite Treatment Market by Gender
5.2.4.1 Male Market size and forecast, by region
5.2.4.2 Female Market size and forecast, by region
5.3 Hard Cellulite
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.3.4 Hard Cellulite Cellulite Treatment Market by Gender
5.3.4.1 Male Market size and forecast, by region
5.3.4.2 Female Market size and forecast, by region
5.4 Edematous
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: CELLULITE TREATMENT MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Clinics and Beauty Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: CELLULITE TREATMENT MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Procedure Type
7.2.3 North America Market size and forecast, by Cellulite Type
7.2.3.1 North America Soft Cellulite Cellulite Treatment Market by Gender
7.2.3.2 North America Hard Cellulite Cellulite Treatment Market by Gender
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Market size and forecast, by Procedure Type
7.2.5.1.2 Market size and forecast, by Cellulite Type
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Procedure Type
7.2.5.2.2 Market size and forecast, by Cellulite Type
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Procedure Type
7.2.5.3.2 Market size and forecast, by Cellulite Type
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Procedure Type
7.3.3 Europe Market size and forecast, by Cellulite Type
7.3.3.1 Europe Soft Cellulite Cellulite Treatment Market by Gender
7.3.3.2 Europe Hard Cellulite Cellulite Treatment Market by Gender
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Procedure Type
7.3.5.1.2 Market size and forecast, by Cellulite Type
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Procedure Type
7.3.5.2.2 Market size and forecast, by Cellulite Type
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Procedure Type
7.3.5.3.2 Market size and forecast, by Cellulite Type
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Procedure Type
7.3.5.4.2 Market size and forecast, by Cellulite Type
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Procedure Type
7.3.5.5.2 Market size and forecast, by Cellulite Type
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Procedure Type
7.3.5.6.2 Market size and forecast, by Cellulite Type
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Procedure Type
7.4.3 Asia-Pacific Market size and forecast, by Cellulite Type
7.4.3.1 Asia-Pacific Soft Cellulite Cellulite Treatment Market by Gender
7.4.3.2 Asia-Pacific Hard Cellulite Cellulite Treatment Market by Gender
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Procedure Type
7.4.5.1.2 Market size and forecast, by Cellulite Type
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Procedure Type
7.4.5.2.2 Market size and forecast, by Cellulite Type
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Procedure Type
7.4.5.3.2 Market size and forecast, by Cellulite Type
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Procedure Type
7.4.5.4.2 Market size and forecast, by Cellulite Type
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Procedure Type
7.4.5.5.2 Market size and forecast, by Cellulite Type
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Procedure Type
7.5.3 LAMEA Market size and forecast, by Cellulite Type
7.5.3.1 LAMEA Soft Cellulite Cellulite Treatment Market by Gender
7.5.3.2 LAMEA Hard Cellulite Cellulite Treatment Market by Gender
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Procedure Type
7.5.5.1.2 Market size and forecast, by Cellulite Type
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Procedure Type
7.5.5.2.2 Market size and forecast, by Cellulite Type
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Procedure Type
7.5.5.3.2 Market size and forecast, by Cellulite Type
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Procedure Type
7.5.5.4.2 Market size and forecast, by Cellulite Type
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Abbvie Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Candela Syneron
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cynosure Technologies
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Merz Pharma GmbH & Co. KGaA
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Bausch Health Companies Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Hologic Inc
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Zimmer Aesthetics
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Galderma SA
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Sinclair Pharmaceuticals Limited
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Endo International plc
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Cellulite Treatment Market,' the cellulite treatment market was valued at $2.1 billion in 2021, and is estimated to reach $5.7 billion by 2031, growing at a CAGR of 10.3% from 2022 to 2031.Cellulite is the herniation of subcutaneous fat within fibrous connective tissue that manifests as skin dimpling and nodularity, often on the pelvic region (specifically the buttocks), lower limbs, and abdomen. Cellulite occurs in most post-pubescent females.
The increase in the prevalence of cellulite and the rise in the obesity rate are the Cellulite Treatment Market Trends that drive the growth of the market. Obesity is the major cause of cellulite in men and women. In addition, an increase in the number of cosmetic procedures is one of the factors that drive the growth of the cellulite treatment market. According to the report shared by the American academy of facial plastic and reconstructive surgery, (AAFPRS), the number of surgical and non-surgical procedures has been reported to be increasing day by day. The rise in the number of cosmetic surgeries, increase in adoption of cosmetic procedures, and surge in demand for minimal invasive cosmetic surgery for improving aesthetic looks, are expected to boost the growth of the global cosmetic implants market.
Furthermore, factors that drive the growth of the Cellulite Treatment Industry include an increase in healthcare expenditure, a rise in the number of cosmetic procedures, and advancements in cellulite treatment. In addition, the surge in demand for attractive physical appearance further contributes to the growth of the Cellulite Treatment Industry.
Moreover, an increase in R&D activities for the development of advanced cellulite treatment tools, new product approvals, and product launches drive the growth of the market. Furthermore, the rise in healthcare expenditure, increase in the number of cosmetic clinics, and improvements in healthcare facilities in developing nations contribute to the growth of the Cellulite Treatment Market Analysis period.
The cellulite treatment market is segmented into procedure type, cellulite type, end user, and region.
On the basis of procedure type, the market is divided into non-invasive, minimal invasive, and topical. The non-invasive segment dominated the Cellulite Treatment Market Size in 2021, and this trend is expected to continue during the forecast period, owing to advancements in non-invasive cellulite treatment, and a rise in demand for non-invasive cellulite treatment.
By cellulite type, the market is categorized into soft cellulite, hard cellulite, and others. The hard cellulite segment dominated the Cellulite Treatment Market Size in 2021, and this trend is expected to continue during the forecast period, owing to an increase in the number of cosmetic procedures and a rise in the prevalence of obesity.
By end user, the market is classified into hospitals, clinics & beauty centers, and others. The clinics & beauty centers segment dominated the Cellulite Treatment Market Share in 2021, and this trend is expected to continue during the forecast period, owing to an increase in the number of clinics & beauty centers and a rise in the prevalence of cellulite.
North America accounted for a majority of the global cellulite treatment market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to the rising prevalence of chronic diseases, the high population base, and the presence of key players in the region. Asia-Pacific is anticipated to witness lucrative growth for Cellulite Treatment Market Forecast period, owing to an increase in the prevalence of chronic diseases, well-established healthcare infrastructure, and a surge in healthcare expenditure.
Key findings of the study
On the basis of procedure type, the non-invasive segment was the highest contributor to the market in 2021.On the basis of cellulite type, the hard cellulite segment was the highest contributor to the market in 2021.
On the basis of end user, the hospital segment was the highest contributor to the market in 2021.
Region wise, North America occupied the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at a significant CAGR during the forecast period.
Companies Mentioned
- Abbvie Inc.
- Candela Syneron
- Cynosure Technologies
- Merz Pharma GmbH & Co. KGaA
- Bausch Health Companies Inc.
- Hologic Inc.
- Zimmer Aesthetics
- Galderma SA
- Sinclair Pharmaceuticals Limited
- Endo International PLC
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 290 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 2140 million |
| Forecasted Market Value ( USD | $ 5729.06 million |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
